Boston Scientific
$43.23Change from previous close: −0.96%Absolute change: −$0.42
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $62.65B
- Enterprise value
- $74.98B
- P/E (trailing 12 months)
- 17.5
- Forward P/E
- 12.7
- PEG
- 0.61
- Price/book
- 2.51
- Price/sales
- 2.98
- EV/EBITDA
- 13.1
- EV/revenue
- 3.57
Profitability and growth
- Gross margin
- 69.2%
- Operating margin
- 22.9%
- Net margin
- 17.5%
- ROE
- 15.3%
- ROA
- 6.2%
- Revenue growth (year over year)
- 7.5%
- Earnings growth (year over year)
- 15.1%
Financial health
- Total cash
- $539M
- Total debt
- $12.62B
- Debt/equity
- 0.50
- Current ratio
- 1.24
- Quick ratio
- 0.56
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $61.00
- Median price target
- $60.00
- High price target
- $94.00
- Low price target
- $44.00
- Analysts with a price target
- 29
- Consensus
- Buy
- Forward EPS
- $3.41
- EPS estimate, current year
- $3.26
Shares and trading
- Beta
- 0.57
- Average volume
- 19.78M
- Shares outstanding
- 1.45B
- Float
- 1.44B
- Institutional ownership
- 95.1%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 3.2%
- Short ratio (days)
- 2.28